Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abexinostat + Doxorubicin in Advanced Sarcoma
NCT01027910Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Feb 2009
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of abexinostat in sarcoma, sponsored by Massachusetts General Hospital. Started Feb 2009; status: completed.
02
Drugs
abexinostat
03
Conditions
sarcoma
Beyond the preview
Go deeper on NCT01027910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01027910.